Palantir revenue surges 93%, but stock seen 30% overvalued at $171.54

Palantir's latest earnings have reignited investor interest in the stock, with the share price climbing about 30% over the past month on the back of 93% revenue growth and a raised 2026 outlook. However, the sharp move has also triggered competing narratives on fair value. The most widely followed view—which values the company at $89 per share—argues that even assuming flawless execution and strong future growth, the stock is overvalued following the recent surge. That narrative rests on rapid revenue compounding and rising margins that it views as too optimistic given the company's heavy dependence on government contracts, a structural vulnerability that limits room for execution missteps.

A contrasting DCF model paints a different picture, estimating fair value near $188.90 and implying the stock is slightly undervalued. This divergence reflects the fundamental challenge in valuing high-growth technology companies: whether the market's pricing reflects sustainable competitive advantage and execution risk, or has gotten ahead of realistic profitability pathways. For investors, the $89–$188.90 range highlights the sensitivity of Palantir's valuation to assumptions about margin expansion and long-term growth sustainability.